{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:06:05Z","timestamp":1789967165619,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf00326634","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T10:46:14Z","timestamp":1098269174000},"page":"5-18","source":"Crossref","is-referenced-by-count":21,"title":["Gram-negative bacteremia"],"prefix":"10.1007","volume":"1","author":[{"given":"Stephen C.","family":"Schimpff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM197703312961302","volume":"295","author":"JB Alavi","year":"1977","unstructured":"Alavi JB, Root RK, Djerassi I, et al (1977) A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 295:706?711","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198809083191001","volume":"319","author":"KS Antman","year":"1988","unstructured":"Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frie E III, Schnipper LE (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593?598","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey GP, Buckley M, Sathe YS (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328?340","journal-title":"Ann Intern Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","volume":"145","author":"GP Bodey","year":"1985","unstructured":"Bodey GP, Jadeja L, Elting L (1985) Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med 145:1621?1629","journal-title":"Arch Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9343(86)90518-8","volume":"81","author":"GP Bodey","year":"1986","unstructured":"Bodey GP, Elting L, Kassamali H, Lim BP (1986) Escherichia coli bacteremia in cancer patients. Am J Med 81:85?95","journal-title":"Am J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198804073181401","volume":"318","author":"SJ Brandt","year":"1988","unstructured":"Brandt SJ, Peters WP, Atwater SK, et al (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318:869?876","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinids\/5.4.629","volume":"5","author":"CS Bryan","year":"1983","unstructured":"Bryan CS, Reynolds KL, Brenner ER (1983) Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 5:629?638","journal-title":"Rev Infect Dis"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/158.2.312","volume":"158","author":"T Calandra","year":"1988","unstructured":"Calandra T, Glauser MP, Schellekens J, Verhoef J, the Swiss-Dutch J5 Immunoglobulin Study Group (1988) Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J Infect Dis 158:312?319","journal-title":"J Infect Dis"},{"key":"CR9","first-page":"31","volume":"39","author":"Centers for Disease Control","year":"1990","unstructured":"Centers for Disease Control (1990) Increase in national hospital discharge summary rates for septicemia ? United States, 1979?1987. MMWR 39:31?34","journal-title":"MMWR"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM197805112981904","volume":"298","author":"RA Clift","year":"1978","unstructured":"Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD (1978) Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 298:1052?1057","journal-title":"N Engl J Med"},{"issue":"Suppl 6B","key":"CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(86)90476-6","volume":"80","author":"P Dejace","year":"1986","unstructured":"Dejace P, Klastersky J (1986) Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med 80 [Suppl 6B]:29?37","journal-title":"Am J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-9343(82)90935-4","volume":"73","author":"CA Jongh de","year":"1982","unstructured":"de Jongh CA, Wade JC, Schimpff SC, Newman KA, Finley RS, Salvatore PC, Moody MR, Standiford HC, Fortner CL, Wiernik PH (1982) Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. Am J Med 73:89?96","journal-title":"Am J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-9343(86)90121-X","volume":"80","author":"CA Jongh de","year":"1986","unstructured":"de Jongh CA, Joshi JH, Newman KA, Moody MR, Wharton R, Standiford HC, Schimpff SC (1986) Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients. Am J Med 80:96?100","journal-title":"Am J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-106-1-7","volume":"106","author":"AW Dekker","year":"1987","unstructured":"Dekker AW, Rozenberg-Arska M, Verhoef J (1987) Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 106:7?12","journal-title":"Ann Intern Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-196907000-00003","volume":"48","author":"HL DuPont","year":"1969","unstructured":"DuPont HL, Spink WW (1969) Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958?1966. Medicine 48:307?332","journal-title":"Medicine"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","volume":"317","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1987","unstructured":"EORTC International Antimicrobial Therapy Cooperative Group (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 317:1692?1698","journal-title":"N Engl J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","volume":"137","author":"EORTC International Antimicrobial Therapy Project Group","year":"1978","unstructured":"EORTC International Antimicrobial Therapy Project Group (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer (writing committee: Schimpff SC, Gaya H, Klastersky J, Tattersall MHN, Zinner SH). J Infect Dis 137:14?29","journal-title":"J Infect Dis"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archinte.1985.00360060149023","volume":"145","author":"R Feld","year":"1985","unstructured":"Feld R, Louis TJ, Mandell L, et al (1985) A multicenter comparative trial of tobramycin and ticarcillin versus moxalactam and ticarcillin in febrile neutropenic patients. Arch Intern Med 145:1083?1088","journal-title":"Arch Intern Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1172\/JCI113751","volume":"82","author":"JL Gabrilove","year":"1988","unstructured":"Gabrilove JL, Jakubowski A, Fain K, et al (1988) Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 82:1454?1461","journal-title":"J Clin Invest"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0140-6736(91)91452-Z","volume":"338","author":"MP Glauser","year":"1991","unstructured":"Glauser MP, Zanetti G, Baumgartner JD, Cohen J (1991) Septic shock: pathogenesis. Lancet 338:732?736","journal-title":"Lancet"},{"key":"CR21","first-page":"1097","volume":"266","author":"RL Greenman","year":"1991","unstructured":"Greenman RL, Schein RMH, Martin MA, et al (1991) A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 266:1097?1102","journal-title":"The XOMA Sepsis Study Group. JAMA"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/IAI.25.2.538-557.1979","volume":"25","author":"SE Greisman","year":"1979","unstructured":"Greisman SE, DuBuy JB, Woodward CL (1979) Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone. Infect Immun 25:538?557","journal-title":"Infect Immun"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198709033171003","volume":"317","author":"JE Groopman","year":"1987","unstructured":"Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW (1987) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317:593?598","journal-title":"N Engl J Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM198911233212106","volume":"321","author":"JE Groopman","year":"1989","unstructured":"Groopman JE, Molina JM, Scadden DT (1989) Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 321:1449?1459","journal-title":"N Engl J Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0002-9343(78)90188-2","volume":"64","author":"M Gurwith","year":"1978","unstructured":"Gurwith M, Brunton JL, Lank B, Ronald AR, Harding GKM, McCullough DW (1978) Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients. Am J Med 64:127?132","journal-title":"Am J Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0002-9343(79)90539-4","volume":"66","author":"MJ Gurwith","year":"1979","unstructured":"Gurwith MJ, Brunton JL, Lank BA, Harding GKM, Ronald AR (1979) A prospective controlled investigation of prophylactic trimethoprim\/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66:248?256","journal-title":"Am J Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0738-1751(88)90027-5","volume":"5","author":"T Horan","year":"1988","unstructured":"Horan T, Culver D, Jarvis W, et al (1988) Pathogens causing nosocomial infections: preliminary data from the National Nosocomial Infections Surveillance System. Antimicrob Newslett 5:65?67","journal-title":"Antimicrob Newslett"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","volume":"297","author":"WT Hughes","year":"1977","unstructured":"Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297:1419?1426","journal-title":"N Engl J Med"},{"key":"CR29","volume-title":"Double beta-lactam versus an aminoglycoside plus beta-lactam combination as empiric therapy for granulocytopenic cancer patients (abstract)","author":"J Joshi","year":"1984","unstructured":"Joshi J, Ruxer R, Newman K, et al (1984) Double beta-lactam versus an aminoglycoside plus beta-lactam combination as empiric therapy for granulocytopenic cancer patients (abstract). Proceedings of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1984, abstract 383. American Society for Microbiology, Washington, DC"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","volume":"106","author":"JE Karp","year":"1987","unstructured":"Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ, Bartlett JG, Saral R, Burke PJ (1987) Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 106:1?7","journal-title":"Ann Intern Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/clinids\/4.2.294","volume":"4","author":"J Klastersky","year":"1982","unstructured":"Klastersky J, Zinner SH (1982) Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis 4:294?301","journal-title":"Rev Infect Dis"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(88)92961-3","volume":"II","author":"H Kodo","year":"1988","unstructured":"Kodo H, Tajika K, Takahashi S, Ozawa K, Asano S, Takaku F (1988) Acceleration of neutrophilic granulocyte recovery after bone-marrow transplantation by the administration of recombinant human granulocyte colony-stimulating factor. Lancet II:38?39","journal-title":"Lancet"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-198401000-00004","volume":"287","author":"RD Lawson","year":"1984","unstructured":"Lawson RD, Gentry LO, Bodey GP, Keating MJ, Smith TL (1984) A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies. Am J Med Sci 287:16?23","journal-title":"Am J Med Sci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9343(80)90243-0","volume":"68","author":"LJ Love","year":"1980","unstructured":"Love LJ, Schimpff SC, Schiffer CA, Wiernik PH (1980) Improved prognosis for granulocytopenic patients with gram-negative bacteremia. Am J Med 68:643?648","journal-title":"Am J Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0891-5520(20)30753-4","volume":"5","author":"MA Martin","year":"1991","unstructured":"Martin MA (1991) Epidemiology and clinical impact of gram-negative sepsis. Infect Dis Clin North Am 5:739?752","journal-title":"Infect Dis Clin North Am"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","volume":"110","author":"WR McCabe","year":"1962","unstructured":"McCabe WR, Jackson GG (1962) Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 110:847?855","journal-title":"Arch Intern Med"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","volume":"155","author":"RD Moore","year":"1987","unstructured":"Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93?99","journal-title":"J Infect Dis"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.V72.2.834.834","volume":"72","author":"J Nemunaitis","year":"1988","unstructured":"Nemunaitis J, Singer JW, Buckner CD, et al (1988) Use of recombinant human granulocyte-macrophage colony-stimulating factors in autologous marrow transplantation for lymphoid malignancies. Blood 72:834?836","journal-title":"Blood"},{"key":"CR39","volume-title":"Supportive care in oncology: infectious complications associated with bone marrow transplantation","author":"WP Peters","year":"1992","unstructured":"Peters WP (1992) Observations on the effects of hematopoietic colony stimulating factors on the clinical course of bone marrow transplantation. In: Schimpff SC, Klastersky J (eds) Supportive care in oncology: infectious complications associated with bone marrow transplantation. Springer, Berlin Heidelberg New York (in press)"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3476(83)80310-2","volume":"102","author":"PA Pizzo","year":"1983","unstructured":"Pizzo PA, Robichaud KJ, Edward B, et al (1983) Oral antibiotic prophylaxis in cancer patients: a double blind randomized placebo-controlled trial. J Pediatr 102:125?133","journal-title":"J Pediatr"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"P Pizzo","year":"1986","unstructured":"Pizzo P, Hathorn J, Hiemenz J, et al (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315:552?558","journal-title":"N Engl J Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM198102123040730","volume":"304","author":"JS Remington","year":"1981","unstructured":"Remington JS, Schimpff SC (1981) Please don't eat the salads. N Engl J Med 304:433?435","journal-title":"N Engl J Med"},{"key":"CR43","first-page":"2257","volume-title":"Principles and practice of infectious diseases","author":"SC Schimpff","year":"1979","unstructured":"Schimpff SC (1979) Infections in the compromised host. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious diseases. Wiley, New York, pp 2257?2262"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","volume":"284","author":"SC Schimpff","year":"1971","unstructured":"Schimpff SC, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284:1061?1065","journal-title":"N Engl J Med"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-77-5-707","volume":"77","author":"SC Schimpff","year":"1972","unstructured":"Schimpff SC, Young VM, Greene WH, Vermeulen G, Moody M, Wiernik P (1972) Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 77:707?714","journal-title":"Ann Intern Med"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/infdis\/130.Supplement.S24","volume":"130","author":"SC Schimpff","year":"1974","unstructured":"Schimpff SC, Greene WH, Young VM, Wiernik PH (1974) Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis 130 [Suppl]:S24-S31","journal-title":"J Infect Dis"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-82-3-351","volume":"82","author":"SC Schimpff","year":"1975","unstructured":"Schimpff SC, Greene WH, Young VM, Fortner CL, Jepsen L, Cusack N, Block JB, Wiernik PH (1975) Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 82:351?358","journal-title":"Ann Intern Med"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0145-2126(78)90041-3","volume":"2","author":"SC Schimpff","year":"1978","unstructured":"Schimpff SC, Hahn DM, Brouillet MD, Young VM, Wiernik PH (1978) Infection prevention in acute leukemia. Comparison of basic infection prevention techniques with standard room reverse isolation or with reverse isolation plus added air filtration. Leuk Res 2:231?240","journal-title":"Leuk Res"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02013473","volume":"5","author":"SC Schimpff","year":"1986","unstructured":"Schimpff SC, Drusano GL, Standiford HC (1986) Serum bactericidal test in volunteers ? a review. Eur J Clin Microbiol 5:71?78","journal-title":"Eur J Clin Microbiol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(84)90662-4","volume":"76","author":"JP Sculier","year":"1984","unstructured":"Sculier JP, Klastersky J (1984) Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med 76:429?435","journal-title":"Am J Med"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(77)90779-6","volume":"II","author":"RA Storring","year":"1977","unstructured":"Storring RA, Jameson B, McElwain TJ, Wiltshaw E, Spiers ASD, Gaya H (1977) Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet II:837?840","journal-title":"Lancet"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM198109103051101","volume":"305","author":"RG Strauss","year":"1981","unstructured":"Strauss RG, Connett JE, Gale RP, et al (1981) A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 305:597?638","journal-title":"N Engl J Med"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/S0022172400022464","volume":"70","author":"D Waaij van der","year":"1972","unstructured":"Waaij D van der, Berghuis-de Vries JM, Lekkerkerk JEC (1972) Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg 70:605","journal-title":"J Hyg"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM198104303041801","volume":"304","author":"JC Wade","year":"1981","unstructured":"Wade JC, Schimpff SC, Hargadon MT, Fortner CL, Young VM, Wiernik PH (1981) A comparison of trimethoprim\/sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304:1057?1062","journal-title":"N Engl J Med"},{"key":"CR55","volume-title":"Imipenem versus piperacillin plus amikacin, empiric therapy for febrile neutropenic patients: a double blind trial (abstract)","author":"JC Wade","year":"1987","unstructured":"Wade JC, Bustamante CI, Devlin A, Finley R, Drusano G, Thompson B (1987) Imipenem versus piperacillin plus amikacin, empiric therapy for febrile neutropenic patients: a double blind trial (abstract). Proceedings of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, NY, 1987, abstract 1251. American Society for Microbiology, Washington, DC"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1056\/NEJM199204233261711","volume":"326","author":"HS Warren","year":"1992","unstructured":"Warren HS, Danner RL, Munford RS (1992) Anti-endotoxin monoclonal antibodies. N Engl J Med 326:1153?1157","journal-title":"N Engl J Med"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJM199204233261710","volume":"326","author":"RP Wenzel","year":"1992","unstructured":"Wenzel RP (1992) Anti-endotoxin monoclonal antibodies ? a second look. N Engl J Med 326:1151?1152","journal-title":"N Engl J Med"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/clinids\/14.4.973","volume":"14","author":"RP Wenzel","year":"1992","unstructured":"Wenzel RP, Andriole VT, Bartlett JG, Batt MD, Bullock WE, Cobbs CG, Light B, Martin MA, Sanford J, Sande MA (1992) Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis 14:973?976","journal-title":"Clin Infect Dis"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","volume":"77","author":"DJ Winston","year":"1984","unstructured":"Winston DJ, Barnes RC, Ho WG, Young LS, Champlin RE, Gale RP (1984) Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am J Med 77:442?450","journal-title":"Am J Med"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0002-9343(86)90633-9","volume":"80","author":"DJ Winston","year":"1986","unstructured":"Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE (1986) Norfloxacin versus vancomycin\/polymyxin for prevention of infection in granulocytopenic patients. Am J Med 80:884?890","journal-title":"Am J Med"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM197410032911411","volume":"291","author":"SM Wolff","year":"1974","unstructured":"Wolff SM, Bennett JV (1974) Gram-negative rod bacteremia. N Engl J Med 291:733?734","journal-title":"N Engl J Med"},{"key":"CR62","first-page":"177","volume-title":"Current clinical topics in infectious diseases","author":"LS Young","year":"1982","unstructured":"Young LS (1982) Combination or single-drug therapy for gram-negative sepsis. In: Remington JS, Swartz MN (eds) Current clinical topics in infectious diseases. McGraw-Hill, New York, pp 177?205"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198211113072001","volume":"307","author":"EJ Ziegler","year":"1982","unstructured":"Ziegler EJ, McCutchan JA, Fierer J, et al (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225?1230","journal-title":"N Engl J Med"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM199102143240701","volume":"324","author":"EJ Ziegler","year":"1991","unstructured":"Ziegler EJ, Fisher CJ, Sprung CL, et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429?436","journal-title":"N Engl J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00326634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00326634\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00326634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T18:05:15Z","timestamp":1624730715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00326634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF00326634"],"URL":"https:\/\/doi.org\/10.1007\/bf00326634","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}